HRV in Oncology and Palliative Medicine

  • Gernot Ernst


Autonomic nervous system dysfunction is a problem that can be detected in about 50–100 % of patients with advanced cancer (Bruera et al. 1986; Walsh and Nelson 2002; Strasser et al. 2006). It has been described in various primary malignancies (Table 13.1).


Heart Rate Variability Holter Monitoring Autonomic Nervous System Dysfunction Carcinoid Heart Disease Heart Rate Variability Change 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. Araujo F, Antelmi I, Pereira AC, et al. Lower heart rate variability is associated with higher serum high-sensitivity C-reactive protein concentration in healthy individuals aged 46 or more. Int J Cardiol. 2006;107:333–7.PubMedCrossRefGoogle Scholar
  2. Brouwer CA, Gietema JA, van den Berg MP, Bink-Boelkens MT, Elzenga NJ, Haaksma J, Kamps WA, Vonk JM, de Vries EG, Postma A. Long-term cardiac follow-up in survivors of a malignant bone tumor. Ann Oncol. 2006;17:1586–91.PubMedCrossRefGoogle Scholar
  3. Bruera E, Chadwick S, Fox R, Hanson J, MacDonald N. Study of cardiovascular autonomic insufficiency in advanced cancer patients. Cancer Treat Rep. 1986;70:1383–7.PubMedGoogle Scholar
  4. Carney RM, Freedland KE, Stein PK, et al. Heart rate variability and markers of inflammation and coagulation in depressed patients with coronary heart disease. J Psychosom Res. 2007;62:463–7.PubMedCrossRefGoogle Scholar
  5. Dekker JM, Crow RS, Folsom AR, Hannan PJ, Liao DP, Swenne CA, Schouten EG. Low heart rate variability in a 2-minute rhythm strip predicts risk of coronary heart disease and mortality from several causes. The ARIC study. Circulation. 2000;102:1239–44.PubMedCrossRefGoogle Scholar
  6. Ekholm E, Rantanen V, Bergman M, Vesalainen R, Antila K, Salminen E. Docetaxel and autonomic cardiovascular control in anthracycline treated breast cancer patients. Anticancer Res. 2000;20:2045–8.PubMedGoogle Scholar
  7. Ernst G, Rostrup M. HRV before and after night shift of nurses. An observational study. 2013b.Google Scholar
  8. Ernst G, Rostrup M. Terminal cancer patients have marked reduced heart rate variability. An observational study. 2013b (to be published).Google Scholar
  9. Fadul N, Strasser F, Palmer JL, Yusuf SW, Guo Y, Li Z, Allo J, Bruera E. The association between autonomic dysfunction and survival in male patients with advanced cancer: a preliminary report. J Pain Symptom Manage. 2010;39:283–90.PubMedCrossRefGoogle Scholar
  10. Fagundes CP, Murray DM, Hwang BS, Gouin JP, Thayer JF, Sollers 3rd JJ, Shapiro CL, Malarkey WB, Kiecolt-Glaser JK. Sympathetic and parasympathetic activity in cancer-related fatigue: more evidence for a physiological substrate in cancer survivors. Psychoneuroendocrinology. 2011;36:1137–47.PubMedCrossRefGoogle Scholar
  11. Glare P, Christakis N. Predicting survival in patients with advanced disease. In: Doyle D et al., editors. Oxford textbook of palliative medicine. 3rd ed. Oxford: Oxford University Press; 2005.Google Scholar
  12. Haegele-Link S, Claus D, Dücker S, Vogt T, Birklein F. Evaluation of the autonomic nervous system using the FAN® device – range of normal and examples of abnormal. Open Neurol J. 2008;2:12–9.PubMedCrossRefGoogle Scholar
  13. Hoffmann J, Grimm W, Menz V, Wied M, Sprenger A, Arnold R, Maisch B. Prognostic value of heart rate variability analysis in patients with carcinoid syndrome. Digestion. 2001;63:35–42.PubMedCrossRefGoogle Scholar
  14. Huikuri HV, Mäkikallio TH, Airaksinen J, Seppänen T, Puuka P, Räihä IJ, Sourander LB. Power-Law relationship of heart rate variability as a predictor of mortality in the elderly. Circulation. 1998;97:2031–6.PubMedCrossRefGoogle Scholar
  15. Inagaki J, Rodriguez V, Bodey GP. Causes of death in cancer patients. Cancer. 1974;33:568–73.PubMedCrossRefGoogle Scholar
  16. Kamath MV, Halton J, Harvey A, Turner-Gomes S, McArthur A, Barr RD. Cardiac autonomic dysfunction in survivors of acute lymphoblastic leukemia in childhood. Int J Oncol. 1998;12:635–40.PubMedGoogle Scholar
  17. Kon H, Nagano M, Tanaka F, et al. Association of decreased variation of R-R interval and elevated serum c-reactive protein level in a general population in Japan. Int Heart J. 2006;47:867–76.PubMedCrossRefGoogle Scholar
  18. Lacount LT, Barbieri R, Park K, Kim J, Brown EN, Kuo B, Napadow V. Static and dynamic autonomic response with increasing nausea perception. Aviat Space Environ Med. 2011;82:424–33.PubMedCrossRefGoogle Scholar
  19. Maltoni M, et al. Successful validation of the palliative prognostic score in terminally ill cancer patients. J Pain Symptom Manage. 1999;17:240–7.PubMedCrossRefGoogle Scholar
  20. Meinardi MT, van der Graaf WT, van Veldhuisen DJ, Gietema JA, de Vries EG, Sleijfer DT. Detection of anthracycline-induced cardiotoxicity. Cancer Treat Rev. 1999;25:237–47.PubMedCrossRefGoogle Scholar
  21. Meinardi MT, van Veldhuisen DJ, Gietema JA, Dolsma WV, Boomsma F, van den Berg MP, Volkers C, Haaksma J, de Vries EG, Sleijfer DT, van der Graaf WT. Prospective evaluation of early cardiac damage induced by epirubicin-containing adjuvant chemotherapy and locoregional radiotherapy in breast cancer patients. J Clin Oncol. 2001;19:2746–53.PubMedGoogle Scholar
  22. Mortara A, Sleight P, Pinna G, et al. Abnormal awake respiratory patterns are common in chronic heart failure and may prevent evaluation of autonomic tone by measures of heart rate variability. Circulation. 1997;96:246–52.PubMedCrossRefGoogle Scholar
  23. Nousiainen T, Vanninen E, Jantunen E, Remes J, Ritanen E, Vuolteenaho O, Hartikainen J. Neuroendocrine changes during the evolution of doxorubicin-induced left ventricular dysfunction in adult lymphoma patients. Clin Sci (Lond). 2001;101:601–7.CrossRefGoogle Scholar
  24. Oxenham D, Cornbleet MA. Accuracy of prediction of survival by different professional groups in a hospice. Palliat Med. 1998;12:117–8.PubMedCrossRefGoogle Scholar
  25. Pirovano M, et al. A new palliative prognostic score: a first step for staging of terminally ill cancer patients. J Pain Symptom Manage. 1999;17:231–9.PubMedCrossRefGoogle Scholar
  26. Ponikowski P, Anker SD, Chua TP, Francis D, Banasiak W, Poole-Wilson PA, Coats AJ, Piepoli M. Oscillatory breathing patterns during wakefulness in patients with chronic heart failure. Circulation. 1999a;100:2418–24.PubMedCrossRefGoogle Scholar
  27. Ponikowski P, Piepoli M, Chua JP, Banasiak W, Francis D, Anker SD, Coats AJ. The impact of cachexia on cardiorespiratory reflex control in chronic heart failure. Eur Heart J. 1999b;20:1667–75.PubMedCrossRefGoogle Scholar
  28. Postma A, Bink-Boelkens MT, Beaufort-Krol GC, Kengen RA, Elzenga NJ, Schasfoort-van Leeuwen MJ, Schraffordt Koops H, Kamps WA. Late cardiotoxicity after treatment for a malignant bone tumor. Med Pediatr Oncol. 1996;26:230–7.PubMedCrossRefGoogle Scholar
  29. Salminen E, Syvänen K, Korpela J, Varpula M, Antila K, Varjo P, Ekholm E. Docetaxel with epirubicin – investigations on cardiac safety. Anticancer Drugs. 2003;14:73–7.PubMedCrossRefGoogle Scholar
  30. Schumacher A. Linear and nonlinear approaches to the analysis of R-R interval variability. Biol Res Nurs. 2004;5:211–21.PubMedCrossRefGoogle Scholar
  31. Strasser F, Palmer JL, Schover LR, Yusuf SW, Pisters K, Vassilopoulou-Sellin R, DeGracia B, Willey JS, Bruera E. The impact of hypogonadism and autonomic dysfunction on fatigue, emotional function, and sexual desire in male patients with advanced cancer: a pilot study. Cancer. 2006;107:2949–57.PubMedCrossRefGoogle Scholar
  32. Syvanen K, Ekholm E, Anttila K, Salminen E. Immediate effects of docetaxel alone or in combination with epirubicin on cardiac function in advanced breast cancer. Anticancer Res. 2003;23:1869–73.PubMedGoogle Scholar
  33. Sztajzel J. Heart rate variability: a noninvasive electrocardiographic method to measure the autonomic nervous system. Swiss Med Wkly. 2004;134:514–22.PubMedGoogle Scholar
  34. Tjeerdsma G, Meinardi MT, van Der Graaf WT, van Den Berg MP, Mulder NH, Crijns HJ, de Vries EG, van Veldhuisen DJ. Early detection of anthracycline induced cardiotoxicity in asymptomatic patients with normal left ventricular systolic function: autonomic versus echocardiographic variables. Heart. 1999;81:419–23.PubMedGoogle Scholar
  35. Walsh D, Nelson KA. Autonomic nerve system dysfunction in advanced cancer. Support Care Cancer. 2002;10:523–8.PubMedCrossRefGoogle Scholar
  36. Ziegler D, Zentai CP, Perz S, et al. Prediction of mortality using measures of cardiac autonomic dysfunction in the diabetic and nondiabetic population: the MONICA/KORA Augsburg Cohort Study. Diabetes Care. 2008;31:556–61.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag London 2014

Authors and Affiliations

  • Gernot Ernst
    • 1
  1. 1.Kongsberg HospitalKongsbergNorway

Personalised recommendations